Zobrazeno 1 - 10
of 179
pro vyhledávání: '"Tom, Børge Johannesen"'
Autor:
Sophie D. Fosså, Anne Holck Storås, Kirsti Aas, Tom Børge Johannesen, Ylva Maria Gjelsvik, Tor Å. Myklebust
Publikováno v:
European Urology Open Science, Vol 63, Iss , Pp 62-70 (2024)
Background and objective: Registry-based studies for prostate cancer (PCa) document higher overall mortality (OM) after high-dose radiotherapy (RT) than after radical prostatectomy (RP). Our aim was to explore the association between pretreatment pat
Externí odkaz:
https://doaj.org/article/23979ec550d6426ab0b163d4d21dc1e6
Autor:
Erlend Skaga, Cassia B. Trewin-Nybråten, Pitt Niehusmann, Tom Børge Johannesen, Kirsten Marienhagen, Leif Oltedal, Stephanie Schipman, Anne Jarstein Skjulsvik, Ole Solheim, Tora Skeidsvoll Solheim, Terje Sundstrøm, Einar O. Vik-Mo, Petter Brandal, Tor Ingebrigtsen
Publikováno v:
Acta Oncologica, Vol 63, Iss 1 (2024)
Background: Surveillance of incidence and survival of central nervous system tumors is essential to monitor disease burden and epidemiological changes, and to allocate health care resources. Here, we describe glioma incidence and survival trends by h
Externí odkaz:
https://doaj.org/article/2fa8de0ecb25480b99d6d0eb23fd7472
Autor:
Erik Skaaheim Haug, Tor Åge Myklebust, Patrick Juliebø‐Jones, Lars Anders Rokne Reisæter, Kirsti Aas, Arne Stenrud Berg, Christoph Müller, Bjørn Hofmann, Øystein Størkersen, Kim L. Nilsen, Tom Børge Johannesen, Christian Beisland
Publikováno v:
BJUI Compass, Vol 4, Iss 3, Pp 331-338 (2023)
Abstract Objectives The aim of this study is to evaluate the 2015 introduction of prebiopsy magnetic resonance imaging of the prostate (MRI‐P) as the standard of care for diagnosing prostate cancer (PCa) by the Norwegian public health care authorit
Externí odkaz:
https://doaj.org/article/6489dd5304ee4e07a761cf65c78eab9c
Autor:
Siri Larønningen, Anna Skog, Gerda Engholm, Jacques Ferlay, Tom Børge Johannesen, Marnar Fríðheim Kristiansen, Daan Knoors, Simon Mathis Kønig, Elinborg J. Olafsdottir, Sasha Pejicic, David Pettersson, Charlotte Wessel Skovlund, Hans H. Storm, Huidong Tian, Bjarte Aagnes, Joonas Miettinen
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
Aim of the articleWe present our new GDPR-compliant federated analysis programme (nordcan.R), how it is used to compute statistics for the Nordic cancer statistics web platform NORDCAN, and demonstrate that it works also with non-Nordic data.Material
Externí odkaz:
https://doaj.org/article/c588399d1281404c9f41c4474a96b669
Autor:
Sophie D. Fosså, Alv A. Dahl, Tom Børge Johannesen, Ylva M. Gjelsvik, Anne Holck Storås, Tor Å. Myklebust
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 37, Iss , Pp 78-84 (2022)
Background: Few studies have described the impact of urinary, bowel and sexual Adverse Health Outcomes (AHOs) on Quality of Life (QoL) in Prostate Cancer Survivors living for more than 5 years after curative radiotherapy (“long-term PCaSs”), and
Externí odkaz:
https://doaj.org/article/4abab58812ce49309fdb1b31622f0591
Autor:
Viggo Jønsson, Haneef Awan, Neil Deaton Jones, Tom Børge Johannesen, Klaus Thøgersen, Bjarni á Steig, Gudrid Andorsdottir, Geir Erland Tjønnfjord
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-11 (2022)
Abstract The heredity of the malignant blood disorders, leukemias, lymphomas and myeloma, has so far been largely unknown. The present study comprises genealogical investigations of one hundred and twelve Scandinavian families with unrelated parents
Externí odkaz:
https://doaj.org/article/39ea54d0406d4e06af4abd66bf928476
Autor:
Ana Gheorghiu, Cathrine Brunborg, Tom Børge Johannesen, John Anker Zwart, Eirik Helseth, Markus Wiedmann
Publikováno v:
Brain and Spine, Vol 3, Iss , Pp 102135- (2023)
Externí odkaz:
https://doaj.org/article/88c125397c1f424ca8475f8147e33fb1
Publikováno v:
Norsk Epidemiologi, Vol 30, Iss 1-2 (2022)
Background: The Cancer Registry of Norway (CRN) has collected data on all Norwegian cancer patients from health providers since 1952. To assess cancer patients’ self-reported late effects and health related quality of life(HRQoL) after treatment, t
Externí odkaz:
https://doaj.org/article/c7af442cf3e44fa6b4d8da8d3a7d8c11
Autor:
Isabelle Deltour, Aslak Harbo Poulsen, Christoffer Johansen, Maria Feychting, Tom Børge Johannesen, Anssi Auvinen, Joachim Schüz
Publikováno v:
Environment International, Vol 168, Iss , Pp 107487- (2022)
Introduction: In the Nordic countries, the use of mobile phones increased sharply in the mid-1990s especially among middle-aged men. We investigated time trends in glioma incidence rates (IR) with the perspective to inform about the plausibility of b
Externí odkaz:
https://doaj.org/article/fd6ab0c8731d4e868f065b258136077c
Autor:
Åslaug Helland, Klaus Kaae Andersen, Tor Åge Myklebust, Tom Børge Johannesen, Jørgen Aarøe, Espen Enerly
Publikováno v:
Cancer Treatment and Research Communications, Vol 33, Iss , Pp 100636- (2022)
Background: Testing for epidermal growth factor receptor mutation (EGFRm) status is a prerequisite to identify eligible patients for tyrosine kinase inhibitors (TKI) treatment. However, EGFR testing of patients with non-small cell lung cancer (NSCLC)
Externí odkaz:
https://doaj.org/article/0c42ead9772a4dc09c777d60766b9333